MedTrace Logo

Supplementation of Standard Antibiotic Therapy With Oral Probiotics for Bacterial Vaginosis

NCT01993524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 594

Last updated 2013-11-25

No results posted yet for this study

Summary

The purpose of this study was to determine whether supplementation of standard antibiotic therapy with oral probiotic preparation prOVag containing lactic acid bacteria influences recurrence of bacterial vaginosis/vaginitis.

Conditions

  • Bacterial Vaginosis
  • Bacterial Vaginitis

Interventions

DIETARY_SUPPLEMENT

probiotic

antibiotic plus probiotic

OTHER

placebo

antibiotic plus placebo

Sponsors & Collaborators

  • IBSS Biomed S.A.

    lead INDUSTRY

Principal Investigators

  • Zbigniew Chelmicki, MD, PhD · "Polis CLINIC" Prywatna Opieka Lekarska Specjalistyczna Sp. z o.o, ul. 1-go Maja 88, 40-240 Katowice, Poland

  • Aleksandra M Cichonska, PhD · IBSS Biomed S.A.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993524 on ClinicalTrials.gov